Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies.
about
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerAdvances in the development of SUMO specific protease (SENP) inhibitorsDownregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factorMolecular markers in prostate cancer. Part I: predicting lethality.Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer.Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice.SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms.Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.Impact of hypoxia on the metastatic potential of human prostate cancer cells.Metastasis-associated gene, mag-1 improves tumour microenvironmental adaptation and potentiates tumour metastasis.The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response.Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality.Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology)Molecular markers in prostate cancer. Part II: potential roles in management.Tumor hypoxia as a driving force in genetic instability.An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.Synergistic action of image-guided radiotherapy and androgen deprivation therapy.HIF-1α downregulation and apoptosis in hypoxic prostate tumor cells infected with oncolytic mammalian orthoreovirus.Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition.Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines.Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line.Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent.Atorvastatin enhances radiosensitivity in hypoxia-induced prostate cancer cells related with HIF-1α inhibition.Homologous Recombination is Activated at Early Time Points Following Exposure to Cobalt Chloride Induced Hypoxic Conditions in Saccharomyces cerevisiae.IDH mutation status in prostate cancer.
P2860
Q26766638-743EE1F3-4FE6-4561-AB37-BDB5944EEB0CQ26864235-0DA66AEB-F8B9-49BC-89F6-C12326ECD379Q28474504-E064E3B6-B948-4277-B07D-FC721599972EQ30373669-69C8EF0A-482D-4E88-866B-50CE7D7A5900Q30393012-5584E4FB-5D93-4BE8-815A-C4A8EB7CF9F3Q31029187-517A1922-DD60-4ED7-8746-C37B89F6D56BQ34056043-0F15EB25-17A2-4166-8AB9-9BB9A28A20E2Q34300803-CDC6EF31-EECF-4DF9-8162-F3658782F50FQ35186588-DA40C5D1-FD63-4648-87C8-4C81C15EA77FQ35370402-55D49B92-665D-45DA-95BA-223180497800Q35753643-2A82EFEB-A0B9-4B51-B6BC-71974757859FQ36184227-2CB03FC0-D3C8-4860-A2A0-977D1B886CF8Q36869865-17B2FB9A-DADF-4F4C-A870-1D5B98F7A0DDQ37237361-DC8F3A0A-2A80-4FD2-AE5E-D0E3E29D6826Q37339702-B68A7284-C209-459E-8179-C5761946E969Q38155002-00BE9F24-ED0B-4436-83D8-E6A76FEEFAEBQ38192714-E8DBB72D-A5C7-46CF-AC95-44063844939EQ38387844-10DAC4D8-B439-4023-974F-CAA64F0DFAD0Q38458133-DC08902C-5028-4E74-9FA1-B0063D62D2E5Q38748006-E3FCD6BB-D38E-4D46-B0E3-E88A5A089993Q39068877-634A694B-962B-4AE5-8130-2560C0960E64Q39069174-A9EB8725-5AA8-4ADE-AF5A-D3CC89C09BEEQ39697464-D5836639-7252-47F7-B867-6C38DB78F3C7Q41464336-F0681958-D680-4901-AECF-4FE3A613260EQ42220017-BD88094D-E07A-45B8-BBCB-F774A4657623Q55462570-F7245845-E45F-42E7-8529-7BCC3DC36DA6
P2860
Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies.
@en
type
label
Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies.
@en
prefLabel
Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies.
@en
P2093
P2860
P356
P1433
P1476
Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies.
@en
P2093
Michael Milosevic
Norman Chan
Robert G Bristow
P2860
P304
P356
10.2217/14796694.3.3.329
P407
P577
2007-06-01T00:00:00Z